アリール炭化水素受容体の世界市場レポート 2025年

アリール炭化水素受容体市場規模は、今後数年間で力強い成長が見込まれます。2029年にはCAGR7.9％で67億9,000万米ドルに成長します。予測期間中の成長は、精密医療への投資の増加、免疫療法への需要の高まり、環境衛生への注力の強化、炎症性疾患への応用の拡大、創薬の継続的な進歩に起因すると考えられます。この期間の主な動向には、標的がん治療の進展、精密医療アプローチの普及、毒物学研究の進展、創薬におけるAIの統合、自己免疫疾患治療の改善などが含まれます。

自己免疫疾患と慢性疾患の増加は、今後数年間のアリール炭化水素受容体（AHR）市場の成長を促進すると予想されます。自己免疫疾患や慢性疾患は、免疫システムの誤作動や健康上の問題が長く続く疾患です。これらの疾患の増加は、遺伝、環境の影響、ライフスタイルの変化、腸内環境のアンバランス、診断能力の向上などの要因と関連しています。AHRアゴニストは、免疫応答と炎症を制御する可能性があり、T細胞の分化と免疫細胞の機能に影響を与えることによって、自己免疫疾患や慢性疾患に対する治療効果を提供します。例えば、2023年7月、スコットランド公衆衛生局は、2022年に新たに多発性硬化症（MS）と診断された症例が前年の85.7％から87.2％増加し、新たに491症例が記録され、合計6,359症例になったと報告しました。その結果、自己免疫疾患や慢性疾患の増加がAHR作動薬市場の成長を促進しています。

AHR市場の企業は、特定の炎症経路を標的とする外用薬など、先進的な治療法の開発に注力しています。これらの治療は、乾癬、多発性硬化症などの自己免疫疾患やその他の慢性炎症性疾患に対する潜在的な解決策を提供すると同時に、全身的な副作用を最小限に抑えるものです。外用薬は皮膚や粘膜に直接塗布し、局所的な症状や病態を治療します。例えば、2022年5月、米国のバイオ医薬品会社であるダーマバント・サイエンシズ社は、VTAMA（タピナロフ）クリーム1％の承認を米国食品医薬品局（FDA）から取得しました。この非ステロイド系治療薬は、選択的AHR調節作用によるユニークな作用機序を持っています。VTAMAは1日1回塗布するよう設計されており、全身への吸収を最小限に抑えながら良好な安全性プロファイルを示しており、従来の治療薬とは一線を画しています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- マクロ経済シナリオ金利、インフレ、地政学、新型コロナウイルス感染症の影響と回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界アリール炭化水素受容体PESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
• 最終用途産業の分析
• 世界のアリール炭化水素受容体市場：成長率分析
• 世界のアリール炭化水素受容体市場の実績：規模と成長, 2019-2024
• 世界のアリール炭化水素受容体市場の予測：規模と成長, 2024-2029, 2034F
• 世界アリール炭化水素受容体総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界のアリール炭化水素受容体市場：タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• CB-993113
• CDR-914K058
• シナバリン酸
• その他のタイプ
• 世界のアリール炭化水素受容体市場：流通チャネル別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 直接販売
• オンラインプラットフォーム
• 販売代理店
• 小売薬局
• 卸売業者
• 世界のアリール炭化水素受容体市場：用途別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 肝細胞がん
• 多発性硬化症
• 肥満
• 骨粗鬆症
• その他の用途
• 世界のアリール炭化水素受容体市場：エンドユーザー業界別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 医薬品
• バイオテクノロジー
• 農業
• 環境コンサルタント
• 調査機関
• 世界のアリール炭化水素受容体市場CB-993113のサブセグメンテーション（タイプ別）、実績と予測, 2019-2024, 2024-2029F, 2034F
• 前臨床段階 CB-993113
• CB-993113の臨床試験
• CB-993113の対象用途
• 世界のアリール炭化水素受容体市場CDR-914K058のサブセグメンテーション（タイプ別）、実績と予測, 2019-2024, 2024-2029F, 2034F
• CDR-914K058の前臨床開発
• 免疫疾患におけるCDR-914K058
• CDR-914K058の標的治療領域
• 世界のアリール炭化水素受容体市場シナバリン酸の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• シナバリン酸の作用機序
• 炎症性疾患におけるシナバリン酸
• 神経変性疾患における潜在的応用
• 世界のアリール炭化水素受容体市場、その他のタイプのサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 合成アリール炭化水素受容体アゴニスト
• 天然アリール炭化水素受容体リガンド
• 新しいアリール炭化水素受容体モジュレーター

第7章 地域別・国別分析

• 世界のアリール炭化水素受容体市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界のアリール炭化水素受容体市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• アリール炭化水素受容体市場：競合情勢
• アリール炭化水素受容体市場：企業プロファイル
  • Bayer AG Overview, Products and Services, Strategy and Financial Analysis
  • Eli Lilly and Company Overview, Products and Services, Strategy and Financial Analysis
  • Organon & Co. Overview, Products and Services, Strategy and Financial Analysis
  • Sigma-Aldrich Corporation Overview, Products and Services, Strategy and Financial Analysis
  • Bio-Techne Corporation Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Abcam plc
• R&D Systems Inc.
• Dermavant Sciences Inc.
• Cayman Chemical Company
• Enzo Life Sciences Inc.
• Tocris Bioscience
• Ikena Oncology Inc.
• MedChemExpress LLC
• Hercules Pharmaceuticals BV
• Active Biotech AB
• AnTolRx Inc.
• Aqilion AB
• Azora Therapeutics Australia Pty Ltd
• Sol-Gel Technologies Ltd.
• Actavalon Inc.

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• アリール炭化水素受容体市場2029：新たな機会を提供する国
• アリール炭化水素受容体市場2029：新たな機会を提供するセグメント
• アリール炭化水素受容体市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

The aryl hydrocarbon receptor is a protein that binds to environmental pollutants, such as dioxins, and regulates gene expression related to immune and inflammatory responses. It is used to modulate various biological processes, including the treatment of autoimmune and inflammatory conditions such as psoriasis, by selectively activating or inhibiting the receptor.

Key types of aryl hydrocarbon receptors include CB-993113, CDR-914K058, cinnabarinic acid, and others. CB-993113 is a small molecule inhibitor that targets the CBP/p300 bromodomain and is being studied for its potential to treat cancer and other diseases by modulating gene expression. These receptors and related compounds are distributed through various channels, such as direct sales, online platforms, distributors, retail pharmacies, and wholesale suppliers. They are used in treating conditions such as hepatocellular carcinoma, multiple sclerosis, obesity, and osteoporosis, and are applied across industries such as pharmaceuticals, biotechnology, agriculture, environmental consultancy, and research institutions.

The aryl hydrocarbon receptor market research report is one of a series of new reports from The Business Research Company that provides aryl hydrocarbon receptor market statistics, including the aryl hydrocarbon receptor industry global market size, regional shares, competitors with the aryl hydrocarbon receptor market share, detailed aryl hydrocarbon receptor market segments, market trends, and opportunities, and any further data you may need to thrive in the aryl hydrocarbon receptor industry. This aryl hydrocarbon receptor market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The aryl hydrocarbon receptor market size has grown strongly in recent years. It will grow from $4.64 billion in 2024 to $5.01 billion in 2025 at a compound annual growth rate (CAGR) of 8.1%. The growth during the historic period can be attributed to factors such as increased awareness of environmental toxins, expanded research in oncology, a surge in autoimmune disease studies, greater interest in targeted therapies, and the growing use of these therapies in drug development.

The aryl hydrocarbon receptor market size is expected to see strong growth in the next few years. It will grow to $6.79 billion in 2029 at a compound annual growth rate (CAGR) of 7.9%. The growth during the forecast period can be attributed to increased investment in precision medicine, rising demand for immunotherapy, a stronger focus on environmental health, expanding applications for inflammatory diseases, and continued advancements in drug discovery. Key trends in this period include progress in targeted cancer therapies, widespread adoption of precision medicine approaches, advancements in toxicology research, the integration of AI in drug discovery, and improvements in autoimmune disease treatments.

The increase in autoimmune diseases and chronic conditions is expected to drive the growth of the aryl hydrocarbon receptor (AHR) market in the coming years. Autoimmune diseases and chronic conditions are long-lasting disorders where the immune system malfunctions or health issues persist. The rise in these conditions is linked to factors such as genetics, environmental influences, lifestyle changes, gut imbalances, and improved diagnostic capabilities. AHR agonists have the potential to regulate immune responses and inflammation, offering therapeutic benefits for autoimmune diseases and chronic conditions by influencing T-cell differentiation and immune cell function. For example, in July 2023, Public Health Scotland reported that newly diagnosed cases of multiple sclerosis (MS) in 2022 increased by 87.2%, compared to 85.7% the previous year, with 491 new cases recorded, bringing the total to 6,359. As a result, the rise in autoimmune diseases and chronic conditions is propelling the growth of the AHR agonist market.

Companies in the AHR market are focusing on developing advanced treatments, such as topical medications that target specific inflammatory pathways. These treatments offer potential solutions for autoimmune diseases such as psoriasis, multiple sclerosis, and other chronic inflammatory conditions while minimizing systemic side effects. Topical medications are applied directly to the skin or mucous membranes to treat localized conditions or symptoms. For example, in May 2022, Dermavant Sciences, a US-based biopharmaceutical company, received approval from the U.S. Food and Drug Administration (FDA) for VTAMA (tapinarof) cream, 1%. This non-steroidal treatment option provides a unique mechanism of action through selective AHR modulation. Designed for once-daily application, VTAMA has shown a favorable safety profile with minimal systemic absorption, setting it apart from traditional therapies.

In September 2024, Organon & Co., a US-based pharmaceutical company, acquired Dermavant Sciences Ltd. for approximately $1.2 billion. This acquisition allows Organon to strengthen its dermatology portfolio by incorporating Dermavant's innovative dermatologic therapy, VTAMA (tapinarof) cream, 1%. Dermavant Sciences Ltd. specializes in developing AHR agonist-based therapies for dermatological conditions.

Major players in the aryl hydrocarbon receptor market are Bayer AG, Eli Lilly and Company, Organon & Co., Sigma-Aldrich Corporation, Bio-Techne Corporation, Abcam plc, R&D Systems Inc., Dermavant Sciences Inc., Cayman Chemical Company, Enzo Life Sciences Inc., Tocris Bioscience, Ikena Oncology Inc., MedChemExpress LLC, Hercules Pharmaceuticals BV, Active Biotech AB, AnTolRx Inc., Aqilion AB, Azora Therapeutics Australia Pty Ltd, Sol-Gel Technologies Ltd., and Actavalon Inc.

North America was the largest region in the aryl hydrocarbon receptor market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in aryl hydrocarbon receptor report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the aryl hydrocarbon receptor market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The aryl hydrocarbon receptor market consists of sales of synthetic AHR agonists, natural AHR agonists, AHR-targeted enzyme inhibitors, and pharmaceuticals targeting AHR pathways. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Aryl Hydrocarbon Receptor Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on aryl hydrocarbon receptor market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for aryl hydrocarbon receptor ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The aryl hydrocarbon receptor market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Type: CB-993113; CDR-914K058; Cinnabarinic Acid; Other Types
• 2) By Distribution Channel: Direct Sales; Online Platforms; Distributors; Retail Pharmacies; Wholesale Suppliers
• 3) By Application: Hepatocellular Carcinoma; Multiple Sclerosis; Obesity; Osteoporosis; Other Applications
• 4) By End-User Industry: Pharmaceuticals; Biotechnology; Agriculture; Environmental Consultancy; Research Institutions
• Subsegments:
• 1) By CB-993113: Preclinical Stage CB-993113; Clinical Trials of CB-993113; Targeted Applications of CB-993113
• 2) By CDR-914K058: Preclinical Development of CDR-914K058; CDR-914K058 in Immunological Disorders; Targeted Therapeutic Areas for CDR-914K058
• 3) By Cinnabarinic Acid: Mechanism Of Action Of Cinnabarinic Acid; Cinnabarinic Acid In Inflammatory Conditions; Potential Applications In Neurodegenerative Diseases
• 4) By Other Types: Synthetic Aryl Hydrocarbon Receptor Agonists; Natural Aryl Hydrocarbon Receptor Ligands; Novel Aryl Hydrocarbon Receptor Modulators
• Companies Mentioned: Bayer AG; Eli Lilly and Company; Organon & Co.; Sigma-Aldrich Corporation; Bio-Techne Corporation
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Aryl Hydrocarbon Receptor Market Characteristics

3. Aryl Hydrocarbon Receptor Market Trends And Strategies

4. Aryl Hydrocarbon Receptor Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Aryl Hydrocarbon Receptor Growth Analysis And Strategic Analysis Framework

• 5.1. Global Aryl Hydrocarbon Receptor PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Aryl Hydrocarbon Receptor Market Growth Rate Analysis
• 5.4. Global Aryl Hydrocarbon Receptor Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Aryl Hydrocarbon Receptor Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Aryl Hydrocarbon Receptor Total Addressable Market (TAM)

6. Aryl Hydrocarbon Receptor Market Segmentation

• 6.1. Global Aryl Hydrocarbon Receptor Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• CB-993113
• CDR-914K058
• Cinnabarinic Acid
• Other Types
• 6.2. Global Aryl Hydrocarbon Receptor Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Direct Sales
• Online Platforms
• Distributors
• Retail Pharmacies
• Wholesale Suppliers
• 6.3. Global Aryl Hydrocarbon Receptor Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hepatocellular Carcinoma
• Multiple Sclerosis
• Obesity
• Osteoporosis
• Other Applications
• 6.4. Global Aryl Hydrocarbon Receptor Market, Segmentation By End-User Industry, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Pharmaceuticals
• Biotechnology
• Agriculture
• Environmental Consultancy
• Research Institutions
• 6.5. Global Aryl Hydrocarbon Receptor Market, Sub-Segmentation Of CB-993113, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Preclinical Stage CB-993113
• Clinical Trials of CB-993113
• Targeted Applications of CB-993113
• 6.6. Global Aryl Hydrocarbon Receptor Market, Sub-Segmentation Of CDR-914K058, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Preclinical Development of CDR-914K058
• CDR-914K058 in Immunological Disorders
• Targeted Therapeutic Areas for CDR-914K058
• 6.7. Global Aryl Hydrocarbon Receptor Market, Sub-Segmentation Of Cinnabarinic Acid, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Mechanism Of Action Of Cinnabarinic Acid
• Cinnabarinic Acid In Inflammatory Conditions
• Potential Applications In Neurodegenerative Diseases
• 6.8. Global Aryl Hydrocarbon Receptor Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Synthetic Aryl Hydrocarbon Receptor Agonists
• Natural Aryl Hydrocarbon Receptor Ligands
• Novel Aryl Hydrocarbon Receptor Modulators

7. Aryl Hydrocarbon Receptor Market Regional And Country Analysis

• 7.1. Global Aryl Hydrocarbon Receptor Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Aryl Hydrocarbon Receptor Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Aryl Hydrocarbon Receptor Market

• 8.1. Asia-Pacific Aryl Hydrocarbon Receptor Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Aryl Hydrocarbon Receptor Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Aryl Hydrocarbon Receptor Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Aryl Hydrocarbon Receptor Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Aryl Hydrocarbon Receptor Market

• 9.1. China Aryl Hydrocarbon Receptor Market Overview
• 9.2. China Aryl Hydrocarbon Receptor Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Aryl Hydrocarbon Receptor Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Aryl Hydrocarbon Receptor Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Aryl Hydrocarbon Receptor Market

• 10.1. India Aryl Hydrocarbon Receptor Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Aryl Hydrocarbon Receptor Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Aryl Hydrocarbon Receptor Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Aryl Hydrocarbon Receptor Market

• 11.1. Japan Aryl Hydrocarbon Receptor Market Overview
• 11.2. Japan Aryl Hydrocarbon Receptor Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Aryl Hydrocarbon Receptor Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Aryl Hydrocarbon Receptor Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Aryl Hydrocarbon Receptor Market

• 12.1. Australia Aryl Hydrocarbon Receptor Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Aryl Hydrocarbon Receptor Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Aryl Hydrocarbon Receptor Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Aryl Hydrocarbon Receptor Market

• 13.1. Indonesia Aryl Hydrocarbon Receptor Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Aryl Hydrocarbon Receptor Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Aryl Hydrocarbon Receptor Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Aryl Hydrocarbon Receptor Market

• 14.1. South Korea Aryl Hydrocarbon Receptor Market Overview
• 14.2. South Korea Aryl Hydrocarbon Receptor Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Aryl Hydrocarbon Receptor Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Aryl Hydrocarbon Receptor Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Aryl Hydrocarbon Receptor Market

• 15.1. Western Europe Aryl Hydrocarbon Receptor Market Overview
• 15.2. Western Europe Aryl Hydrocarbon Receptor Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Aryl Hydrocarbon Receptor Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Aryl Hydrocarbon Receptor Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Aryl Hydrocarbon Receptor Market

• 16.1. UK Aryl Hydrocarbon Receptor Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Aryl Hydrocarbon Receptor Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Aryl Hydrocarbon Receptor Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Aryl Hydrocarbon Receptor Market

• 17.1. Germany Aryl Hydrocarbon Receptor Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Aryl Hydrocarbon Receptor Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Aryl Hydrocarbon Receptor Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Aryl Hydrocarbon Receptor Market

• 18.1. France Aryl Hydrocarbon Receptor Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Aryl Hydrocarbon Receptor Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Aryl Hydrocarbon Receptor Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Aryl Hydrocarbon Receptor Market

• 19.1. Italy Aryl Hydrocarbon Receptor Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Aryl Hydrocarbon Receptor Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Aryl Hydrocarbon Receptor Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Aryl Hydrocarbon Receptor Market

• 20.1. Spain Aryl Hydrocarbon Receptor Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Aryl Hydrocarbon Receptor Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Aryl Hydrocarbon Receptor Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Aryl Hydrocarbon Receptor Market

• 21.1. Eastern Europe Aryl Hydrocarbon Receptor Market Overview
• 21.2. Eastern Europe Aryl Hydrocarbon Receptor Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Aryl Hydrocarbon Receptor Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Aryl Hydrocarbon Receptor Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Aryl Hydrocarbon Receptor Market

• 22.1. Russia Aryl Hydrocarbon Receptor Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Aryl Hydrocarbon Receptor Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Aryl Hydrocarbon Receptor Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Aryl Hydrocarbon Receptor Market

• 23.1. North America Aryl Hydrocarbon Receptor Market Overview
• 23.2. North America Aryl Hydrocarbon Receptor Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Aryl Hydrocarbon Receptor Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Aryl Hydrocarbon Receptor Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Aryl Hydrocarbon Receptor Market

• 24.1. USA Aryl Hydrocarbon Receptor Market Overview
• 24.2. USA Aryl Hydrocarbon Receptor Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Aryl Hydrocarbon Receptor Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Aryl Hydrocarbon Receptor Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Aryl Hydrocarbon Receptor Market

• 25.1. Canada Aryl Hydrocarbon Receptor Market Overview
• 25.2. Canada Aryl Hydrocarbon Receptor Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Aryl Hydrocarbon Receptor Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Aryl Hydrocarbon Receptor Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Aryl Hydrocarbon Receptor Market

• 26.1. South America Aryl Hydrocarbon Receptor Market Overview
• 26.2. South America Aryl Hydrocarbon Receptor Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Aryl Hydrocarbon Receptor Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Aryl Hydrocarbon Receptor Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Aryl Hydrocarbon Receptor Market

• 27.1. Brazil Aryl Hydrocarbon Receptor Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Aryl Hydrocarbon Receptor Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Aryl Hydrocarbon Receptor Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Aryl Hydrocarbon Receptor Market

• 28.1. Middle East Aryl Hydrocarbon Receptor Market Overview
• 28.2. Middle East Aryl Hydrocarbon Receptor Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Aryl Hydrocarbon Receptor Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Aryl Hydrocarbon Receptor Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Aryl Hydrocarbon Receptor Market

• 29.1. Africa Aryl Hydrocarbon Receptor Market Overview
• 29.2. Africa Aryl Hydrocarbon Receptor Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Aryl Hydrocarbon Receptor Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Aryl Hydrocarbon Receptor Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Aryl Hydrocarbon Receptor Market Competitive Landscape And Company Profiles

• 30.1. Aryl Hydrocarbon Receptor Market Competitive Landscape
• 30.2. Aryl Hydrocarbon Receptor Market Company Profiles
  • 30.2.1. Bayer AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Eli Lilly and Company Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Organon & Co. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Sigma-Aldrich Corporation Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Bio-Techne Corporation Overview, Products and Services, Strategy and Financial Analysis

31. Aryl Hydrocarbon Receptor Market Other Major And Innovative Companies

• 31.1. Abcam plc
• 31.2. R&D Systems Inc.
• 31.3. Dermavant Sciences Inc.
• 31.4. Cayman Chemical Company
• 31.5. Enzo Life Sciences Inc.
• 31.6. Tocris Bioscience
• 31.7. Ikena Oncology Inc.
• 31.8. MedChemExpress LLC
• 31.9. Hercules Pharmaceuticals BV
• 31.10. Active Biotech AB
• 31.11. AnTolRx Inc.
• 31.12. Aqilion AB
• 31.13. Azora Therapeutics Australia Pty Ltd
• 31.14. Sol-Gel Technologies Ltd.
• 31.15. Actavalon Inc.

32. Global Aryl Hydrocarbon Receptor Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Aryl Hydrocarbon Receptor Market

34. Recent Developments In The Aryl Hydrocarbon Receptor Market

35. Aryl Hydrocarbon Receptor Market High Potential Countries, Segments and Strategies

• 35.1 Aryl Hydrocarbon Receptor Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Aryl Hydrocarbon Receptor Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Aryl Hydrocarbon Receptor Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer